The results of our experiments showed that, compared with PFD and hUC-MSC treatment alone, the combination of hUC-MSCs and PFD increased RGS2 protein levels, significantly decreased intracellular Ca2+ concentration, and significantly reduced fibrosis markers. The gene discussed is RGS2; the disease is polyostotic fibrous dysplasia.